Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06157541
Title T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma (TCaP)
Acronym TCaP
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Queensland Institute of Medical Research
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS


No variant requirements are available.